<DOC>
	<DOC>NCT00074529</DOC>
	<brief_summary>An investigational drug (MK0677) will be studied to determine whether it helps the memory and cognition of patients with Alzheimer's Disease.</brief_summary>
	<brief_title>Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Patients must have probable Alzheimer's disease of mild or moderate severity. A brain scan and laboratory results must be consistent with Alzheimer's disease. The patient must be otherwise medically healthy.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>